ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Tertiary Lymphoid Structures Are Associated with a Favorable Prognosis in High-Grade Serous Ovarian Cancer Patients

Zhang, Ke; Xie, Xiao; Zou, Li-Hao; Guo, Sui-Qun*南方医科大学
Reproductive Sciences2023-8DOI: 10.1007/s43032-023-01188-x
1被引12阅读
引用收藏
分享

摘要

There was accumulating evidence indicating that tertiary lymphoid structures (TLSs) were strongly associated with improved survival and clinical outcome in several solid tumors. In this study, we intended to assess the presence of TLSs and their potential clinical significance in high-grade serous ovarian cancer (HGSOC). TCGA (The Cancer Genome Atlas) cohort included RNA-seq data of 376 HGSOC patients, of which 74 patients included available hematoxylin-eosin (H&E) sections; GEO (Gene Expression Omnibus) cohort, GSE140082, included microarray data of 212 HGSOC patients. TLSs were counted by pathological sections, and the relative abundance of TLSs was assessed by the unsupervised consensus clustering of 12-chemokine transcriptome signatures. The potential associations between TLSs and clinical prognosis, tumor microenvironment (TME), and immunotherapy response of HGSOC were further performed based on transcriptome data. In the H&E sections of HGSOC, TLSs were predominantly located in the stroma and invasive margin of the tumor. Pathological counting results suggested that the expression of 12 chemokines was significantly higher in samples abundant with TLSs than that in the lack of TLSs. Consensus clustering of both TCGA and GEO cohorts divided HGSOC patients into two clusters with different TLSs abundance: low- and high-TLSs. Based on transcriptome analysis, the high-TLS cluster was characterized by better clinical prognosis, a higher degree of immune infiltration, more biological pathways, higher tumor mutational burden score, and higher expression of immune checkpoints. In conclusion, TLSs strongly correlated with the immune-responsive microenvironment and remained a favorable prognostic factor independent of other clinical characteristics in HGSOC. The presence of TLSs was also associated with a potentially favorable response to immune checkpoint blockade (ICB) therapy in HGSOC.

学科与关键词

关键词
High-grade serous ovarian cancer (HGSOC)Tertiary lymphoid structures (TLSs)12-Chemokine signaturesFavorable prognosisImmune checkpoint blockade (ICB)
相关
加载中…
  • Tertiary lymphoid structures in gynecological cancers: prognostic role, methods for evaluating, antitumor immunity, and induction for therapy
    Zhang, Ke; Xie, Xiao; Zheng, Shuang-Lin; Deng, Yuan-Run; Liao, Dan; Yan, Hai-Chen; Kang, Xi; Jiang, Hui-Ping*; Guo, Sui-Qun*Frontiers in Oncology, 2023, 13: 1276907.
  • Spatial heterogeneity of infiltrating T cells in high- grade serous ovarian cancer revealed by multi-omics analysis
    Yang, Bin; Li, Xiong; Zhang, Wei; Fan, Junpeng; Zhou, Yong; Li, Wenting; Yin, Jingjing; Yang, Xiaohang; Guo, Ensong; Li, Xi; Fu, Yu; Liu, Si; Hu, Dianxing; Qin, Xu; Dou, Yingyu; Xiao, Rourou; Lu, Funian; Wang, Zizhuo; Qin, Tianyu; Wang, Wei; Zhang, Qinghua; Li, Shuaicheng; Ma, Ding; Mills, Gordon B.; Chen, Gang*; Sun, Chaoyang*CELL REPORTS MEDICINE, 2022, 3(12): 100856.被引 14
  • Immuno-genomic characterisation of high-grade serous ovarian cancer reveals immune evasion mechanisms and identifies an immunological subtype with a favourable prognosis and improved therapeutic efficacy
    Sun, Jie; Yan, Congcong; Xu, Dandan; Zhang, Zicheng; Li, Ke; Li, Xiaobo; Zhou, Meng*; Hao, Dapeng*British Journal of Cancer, 2022, 126(11): 1570-1580.被引 18
查看全部 →

发表信息

论文状态
公开发表
期刊
Reproductive Sciences
发表日期
2023-08
卷期
第 30 卷, 第 8 期
页码
2468-2480
DOI
10.1007/s43032-023-01188-x
语言
ENGLISH
成果收录
SCIE

作者

  • Z

    Zhang, Ke (第一作者)

    southern med univ

  • X

    Xie, Xiao

    southern med univ

查看全部 4 位作者收起作者
  • Z

    Zou, Li-Hao

    southern med univ

  • G

    Guo, Sui-Qun (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417